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ABSTRACT 
Hyperpolarization-activated  and  Cyclic  Nucleotide-gated  (HCN)  channels  with  significant  physiological  role  are  found  to  be  present  in  heart  
and  brain.  These  channels  have  got  four  subtypes  encoded  by  four  different  genes.  They  play  significant  role  in  maintainance  of  cardiac  
rhythm  and  neuronal  excitability  with  definite  but  partially  defined  role  in  development  of  arrhythmia,   epilepsy  and  neuropathic  pain.  
These are  also  known  as  pace  maker  channels.  In  present  review  we  will  mainly  discuss  electrophysiology  of  neurons  and  SA  node  in  
special  reference  to  HCN  channel.  In  the  heart  mainly  HCN4  subtype  is  present  while  in  brain  all four  isotype  have  been  found  where  
they  are  involved  in  numerous  neuronal  functions  i.e.  dendrite c  integration,  memory,  thalamo-cortical  rhythm  etc.  Further  in  review  we  
will  also  discuss  in  brief  the  physiology  and  uniqueness  of  this  ion  channel  and  disorders  especially  epilepsy,  neuropathic  pain  and  
cardiac  arrhythmia,  due  to  the  malfunctioning  of  these  ion  channels.  The  newer  possibilities  of  modifying  this  ion  channel  along  with  the  
drugs  acting  will  also  be  discussed. 
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 INTRODUCTION 
Rhythm,  classically  defined  as  any  motion  characterized  by  
regular  recurrence  or  pattern  in  time  which  can  be  applied  to  
numerous  cyclical  natural  phenomena  with  periodicity.  The  
rhythmic  character  can  be  observed  in  numerous  natural  
systems  including  human  body.  There  are  various  activities  
which  require  considerable  synchronizing  activities  e.g.  Pace  
maker,  central  pattern  generator,  motor  co-ordination,  
perception  etc.  Out  of  these  numerous  activities  we  will  mainly  
focus  on  activities  associated  with  heart  and  brain.  As  these  
actions  are  vital  to  various  physiological  activities,  there  
malfunctioning  can  result  in  disease  states.  The  variety  of  
factors  play  critical  role  in  maintaining  the  rhythmicity  in  
sinoatrial  (SA)  node    as  well  as  neuronal  synchronization.  There  
are  numerous  ion  channels  are  involved  in  maintaining  this  
normal  physiological  rhythm  of  SA  node   including  
hyperpolarization-activated  cyclic  nucleotide-gated  (HCN)  
channels.  HCN  channels  initially  referred  to  as  pacemaker  
channels[1],  supposed  to  have  a    key  role  in  the  control  of  
heart  rate  and  neuronal  excitability  as  they  help  to  generate  
rhythmic  activity  within  groups  of  heart  and  brain  cells.  These  
channels  belong  to  the  family  of  cyclic  nucleotide  regulated  
channels  and  function  as  nonselective  ligand-gated  cation  
channels.  Cyclic  nucleotide  regulated  channels  also  include  cyclic  
nucleotide-gated  (CNG)  channels.  The  activation  of  CNG  channel  
is  mediated  by  direct  binding  of    cGMP  or  cAMP  to  the  channel  
itself[2,3].    CNG  channels  are  permeable  to  both  K+  and  Na  +  
ions.  Since  the  CNG  channels  are  activated  by  second  messanger  
they  offer  a  certain  mechanism  through  which  the  concentration  
of  second  messanger  can  directly  alter  the  membrane  
excitability.  In  the  manner  similar  to  CNG  channels  the  HCN  
channels  are  also  activated  by  second  messanger.  The  difference  
between  these  two  lies  in  the  fact  that  CNG  channels  are  
independent  of  voltage  while  HCN  channels  are  voltage  
dependent[4].  These  are  some  of  the  distinguishing  features  of  
HCN channels  from  CNG.  HCN  channels  comprise  four  subtypes  
which   are   encoded    by    four    separate    genes  i.e.   HCN1-45.  
Functionally,  they  differ  from  each    other     in     terms      of    time  
 
constant  of  activation  (HCN1  being  the  fastest  and  HCN4  
slowest)[6]  and   sensitivity  to  cAMP.  Both  cyclic  nucleotides  i.e.  
cAMP and cGMP  are  full  agonists  of  these  channels  at  saturating  
concentrations[7].  These  channels  are  found  in  various  sites  in  
human  body  but  in  this  review  we  will  focus  mainly  on  their  
distribution  in  brain  and  heart.  In  the  central  nervous  system  
HCN1  is  expressed  in  neocortex,  hippocampus,  brainstem,  
cerebellar  cortex,  spinal  cord[8-12].  HCN2  is  mainly  present  in  
thalamus  and  brain  stem [9-11].  HCN3  is  present  in  olfactory  
bulb[9-10].  HCN4  is  usually  present  in  thalamic  nuclei  and  
olfactory  bulb[9-11].  In  the  heart  every  subtype  have  been  
found  and  expression  of  particular  subtype  varies  in  between  
different  regions  of  heart.  HCN4  is  the  major  subtype  present  in  
SA  node[13],  AV  node[14]  and  purkinje  fibres[15].  
Unique Features of HCN Channels 
The  HCN  channels  possess  remarkably  different  properties  and  
different  kinetics  from  other  voltage  gated  ion  channels.  In  the  
above  section  we  have  discussed  some  of  the  properties.  
Further  in  continuation  although   these  channels   are  structurally  
similar  to  K+ ion  channels  they  show  relatively  less  selectivity  
for  K+   and  they  are  better  permeable  for  Na+ [16,17].  In  
contrast  to  other  voltage  gated  ion  channels,  they  are   partially  
open  at  resting  membrane  potential   and  their  activation  
increases  with  hyperpolarization,  hence  we  can  conclude  that  
resting  state  of  cells  activate  them  while  depolarizing  state  turn   
them  off.  It  seems  it  is  the  fine  balance  between  active  and  
relative  inactive  state  which  is  exquisitely  sensitive  to  the  minor  
changes  in  membrane  potential  may  provide  stability  to  
neuronal  and  cardiac  cells  may  also  contribute  to  rhythmicity.  
As  these  channels  show  constitutive  activity  i.e.  they  are  active  
even  in  resting  condition,  this  itself  signifies  their  important  
role  in  membrane  physiology.  As  quoted  earlier  in  the  article  
these  channels  are  also  modulated  by  second  messanger  e.g.  
cAMP,  this  is  another  circumstantial  evidence  that  these  
channels  are  tuned  in  such  a  manner  so  as  to  provide  stability  
to  the  cell.  From  above  discussion  we  can  infer  that  HCN  
channels  are  nature’s  mechanism  to  prevent  over  stimulation  of  
cell.  With  this  background  we  now  will  discuss  the  physiological  
role  of  HCN  in  heart  and  brain. 
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Role  of  HCN  Channels  in  Cardiovascular  Physiology 
 SA  node  has  got  prominent  role  in  generation  of  heart  beat  
and  maintaining  the  automaticity  of  heart  beat  because  of  
generation  of  pacemaker  potential  defined  by  diastolic  
depolarization  in  the  voltage  range  of  -65  to  -45mV.  It  is  the  
diastolic  depolarization  which  causes  membrane  potential  of  SA  
node  back  to  threshold,  hence  maintaining  the  automaticity.  The  
current  produced  by  HCN  channel  is  known  as  Ih,  Iq   or  If  
where  the  subscript  stands  for  hyperpolarization,  queer  and  
funny  respectively  and  is  supposed  to  play  prominent  role  in  
diastolic  depolarization[18]  along  with  the  other  ionic  currents.  
Other  factors  responsible  for  diastolic  depolarization  are  
sarcoplamic  release  of  calcium  through  ryanodine  receptors[19],  
the  sustained  inward  current  Ist[20],  T-type  Ca++  current 
(ICa,T)[21], and  L-type Ca++  current  (ICa,L)[22].  
If  currents  are  inward  current  activated  on  hyperpolarization  to  
the  diastolic  range  of  voltages,  have  characteristics  suitable  for  
generating  automaticity  and  for  modulating  spontaneous  heart  
rate.  As   If  currents   are  controlled  by  intracellular  cAMP  hence  
they  are  activated  and  inhibited  by  adrenergic  and  muscarinic 
M2 receptor stimulation  respectively,  which  represents a basic 
mechanism  through  which  effects  of  autonomic  nervous  system  
on  the  heart  are  mediated.   
Since  HCN4  is  major  subtype  present  in  SA  node  so  deletion  of    
its  gene  in  animal  model  certainly  will  have  detrimental  effects.  
There  are  definite  evidence  from  different  studies  that  mouse  
embryos  which  were  lacking  functional  HCN4  failed  to  develop  
during  the  embryonic  period  and  died  in  utero[23,24].  On  the  
other  hand    their  role  in  adult  mice  is  not  very  clear  as  they  
are  rarely  affected24,  although  the  intensity  of  If  declined  but  
the  SA  node  activity  didn’t  affected  much  probably  indicating  
presence  of  alternative   mechanisms  to  overcome  the  defect.  
HCN2  is  also  present  and  their  deletion  can  cause  sinus  
dysrhythmia  characterized by varying peak-peak intervals in the 
electrocardiogram [25].  Here  it  can  be  concluded  that  these  
channels  are  important  for  embryonic  development  and  
development  of  adult  pace-making  system.                                 
Role  of  HCN  Channels  in  Neuronal  Physiology             
 As  mentoined  earlier  these  currents  have  certain  unique  
features  which  are  important  for  electrical  responsiveness  of  
cell.  These  channels  are  partially  active  at  rest,  activated  at  
hyperpolarization  and  deactivated   at  depolarization,  with  the  
property  of   negative  feedback  which  resists  both  inhibitory  and  
excitatory  stimuli  which  eventually   helps  cell  to  maintain  its  
memebrane  potential.  These  channels  are  constitutively  active  at  
resting  membrane  potential  and  act  as  “voltage  clamp” [26]  that  
tends  to  stabilize  membrane  potential.  Ih  have  got  definite  role  
to  play  in  the numerous  basic and  higher   neuronal functions  and  
we  will  discuss  it  one  by  one.                             
All  four  subtypes  of  HCN  are  found  in  brain [27].  The  Ih  limits  
hippocampal  long  term  potentiation  (LTP)  indicated  by  
enhancement  of  hippocampal  learning  and  memory  in  the mice  
with  selective  deletion  of  HCN1  gene[28,29].  High  HCN1  
expression  probably  interferes  with  the  generation  of  calcium  
spikes  associated  with  LTP29 .  On  the  contrary  the  HCN  
increased  spatial  working  memory  which  is  concerned  with  
immediate  conscious  perceptual  and  linguistic  processing  which  
actively  holds  multiple  pieces  of transitory  information  in  the  
mind,  where  they  can  be  manipulated  and  it  depends  on  
prefrontal  cortex.  There is  complex  interaction  between  HCN  and  
alpha-2  adrenergic  receptor  in  prefrontal  cortex  which  results  in  
increased  efficiency  of  synaptic  input,  and  the  activity  of  these  
neurons  increases[30].  Complex  motor  learning   and  memory  
requiring  repeated  co-ordination  which  involve  cerebellar  circuit  
are  badly  influenced  by  deletion  of  HCN1  gene [31].  Most  
neurons  have  elaborately  branching  dendritic  trees  that  receive   
thousands  of  synaptic  inputs  which  may  be  excitatory  or  
inhibitory  and  their  processing  requires  dendritic  integration.  A  
single  EPSP  can  not  generate  action  potential  hence  it  requires  
integration  of  multiple  synaptic  inputs  spatially  as well  as  
temporally.  There  is  a  proven  role  of  Ih  in  this  complex  
process[32].  Most  important  physiologic  action  where  Ih  
participate  is  thalamocortical  (TC)  rhythms.  Oscillatory  activity  
is  an  emerging  property  of  the thalamocortical  system  which  can  
be  generated  alone  by  a  single  neurons  or  in  coordination  with  
other  neurons.  The  various  types  of  oscillations  within  TC  
system  are  infra-slow  oscillations,  slow  oscillations,  delta  
oscillations,  sleep  spindle  oscillations,  beta-gamma  oscillations,  
and  ripples. Thalamocortical  oscillations  are  produced  in  
thalamocortical networks  during  sleep[33],  sensory  
processing[34],  and  seizures[35].  Various  models  and  hypotheses  
have  been  proposed  to  describe  the  contribution  of  Ih  in  TC  
oscillations  and  neuronal  physiology,  detailed  discussion  of  
which  is  not  required  in  this  particular  article.                                       
Disorders  of  HCN  Channel  Malfunctioning 
 In  the  previous  section  we  have  discussed  the  significant  
physiological  role  of  HCN  channel  in  neuronal  and  cardiac  
physiology  and  their  malfunctioning  can  result  in  variety  of  
disorders  especially  in  brain.  These  channels  are   found  to  be  
involved  in  epilepsy[36],  neuropathic  pain[37]  and  cardiac  
arrhythmia25  and  others.  we  will only  focus  on  these  three  
disorders.                                            
Epilepsy  is  characterized  by   the  occurrence  of  spontaneous 
seizures,  i.e.,  bursts  of  synchronous  firing  of  large  populations  of  
neurons.  These  are believed  to  result  from  abnormal  regulation  
of  neuronal  excitability.  It  was  year  2001  when  HCN  channels  
were  implicated  in  epilepsy[38],  since  then   role  of HCN  
channels  in  epilepsy  is  a  matter  of  debate.  Epileptogenesis  
involves  alterations  in  variety  of  ion  channels  which  may  be  
inherited  or  acquired.  In  the  hippocampal  neurons   HCN  
channels  are  predominantly  present  in  apical  dendrites  and  play  
important  role  in  dendritic  integration  and  attenuates  neuronal  
excitability 32.  It  has  been  shown  in  many  studies  that  down  
regulation  of  HCN  channel  is  associated  with  increase  in  
neuronal  excitability  which  contributes  to  
epileptogenesis[39,40,41].  HCN2  null mice  show  absence  epilepsy 
25  while  HCN1  null  mice  are  more  susceptible  to  kainic  acid-
induced  seizures41.  From  animal  studies  we  have  came  to  know  
that  HCN  channels  have  got  neuron  modulating  activity  and  
their  malfunctioning  can  result  in  epileptiform  activity  such  
correlation  can  also  be  observed  in  human  beings[42,43]  as  
evidenced  by  enhanced  levels  of  HCN1  channel  expression  in  
dentate  gyrus  resected  hippocampal  nuclei  in  patients  of  
temporal  lobe  epilepsy[44].  Since  HCN  channels  work  in  sea-saw  
fashion  with  multiple functions  of  neuronal activity which  are  
context  and  location  dependent,  their  upregulation  or  
downregulation   both  can  result  in  disease  state.  Further  the  
findings  from  animal  models  may  not  always  be  replicated  in  
human  also.  We  can  c onclude  that  at  least  defect  in  HCN  can  
provoke  seizures  and  it  will  be  oversimplification  to  explain  
mechanism  of  epileptogenesis  in  generalized  model  of  epilepsy.  
To  explain  the  exact  mechanism  we  need  to  have  specific  
models  of  epilepsy  under  different  patho-physiologic  settings.   
Neuropathic  pain  is  a  symptom  of  diseases  damaging  nerves 
characterized  by  allodynia  and  dysesthesia  and  is  believed  to  be 
due  to  abnormal  activity  of  neurons  of  dorsal  root  ganglion[45].  
The  HCN  channels  have  been  found  to  be  present in  dorsal  root  
ganglion[46]  and  Ih  has  been  found  to  be  involved  in  
generation  of  ectopic  discharges  in  DRG  neurons[47].  There  is  
evidence  that  after  axonal  injury  the  HCN  channel  contribute  to 
abnormal  activity  in peripheral  nerves48.  HCN1  has  been  found  
to  be  up-regulated  in  case  of  damaged  nerve  evoking  
spontaneous  pacemaker  driven  action  potential [48].  Pain  
intensity  mainly  depends  on  the  firing  rate  of  neurons,  and  it  
can  be  modulated  by  HCN  channels  as  HCN2  ion  channel is  now  
known  to  be  a  key  downstream  target  in  the  cellular  events  
associated  with  pain[49].  In  animal  model  of  acute  and  chronic  
pain  it  had  been  shown  that  Ih  expression  and  modulation  in  
the  peripheral  nervous  system,  including specialized  sensory  
structures,  may  play  a  significant  role  in  sensory  processing  and 
Singh et al. 




contribute  to  spontaneous  pain  and  tactile  allodynia[50].  The  
peripheral  block  of  HCN  channel  by  ZD7288  produces  
antiallodynic  effect  which indicates  these  channels represent a 
novel  target  for  nerve  block  treatment  of  postoperative  and  
neuropathic  pain[51].  From  above  discussion  we  can  conclude  
that  the  expression  of  these  channels  is  increased  in  nerve  
injury  and  their  inhibition  with  the  drugs  is  likely  to  benefit  in  
the  disease.  In  the  future  it  is  expected  to  play  significant  role  
in  neuropathic  pain. 
HCN  channels  are  found  to  be  present  in  virtually  every  heart  
with  HCN4  and  HCN2  are  major  subtypes.  Although  these  
channels  are not  solely  responsible  for  maintainance  of  rhythm  
but  their  genetic  alteration  or  malfunctioning  can  result  in  
arrhythmia.  Molecular techniques  have been  tried  to delineate   
the relationships  between  mutations  of  the  HCN channels  genes  
and  alterations  in  the  cardiac  function.  A  missense mutation  in  
hHCN4  gene  induces  the  production  of  an  isoform  of  the  
pacemaker  channel with  altered  cAMP  binding  site  this  was  
supposed  to  be  responsible  for  a  familial  form of  an  
asymptomatic  bradycardia[52].  There  exists  four  different  types  
of  mutations  associated  with  different  types  of  arrhythmia  in  
the  human  isoform  of  the  HCN4  channel[53].  Increased  
ventricular  expression  of  HCN  channels  possibly  contributes  to  
the ventricular  arrhythmias[54].  Loss  of  function  of  HCN4  is  
associated  with  sinus  nodal   dysfunction  and  that  a  consequence  
of  pacemaker  channel  abnormality  might  underlie clinical  
features  of   QT   prolongation  and  polymorphic  ventricular  
tachycardia  developed   under  certain  conditions[55].  HCN 
 channels  were  suggested  to  contribute  to  the  shortening of  the  
action  potential  duration  and  the  prevention  of  early  after-
depolarization  in bradycardia  which  suggests  that  the  HCN4  
channel  played  a  preventive  role  in  triggering  bradycardia-
induced  ventricular  arrhythmias[56].   Considering  the  functional  
complexity  of  HCN  channel  in  regulation  of  cardiac  rhythm  and  
their  upregulation  and  downregulation  both  are  associated  with  
diseased  cardiac  states  it is  difficult  to  understand  specific  
phenotypic  aspect  associated  with  the  mutation.  More  studies  
are  required  to  detect  the  exact  role  of  HCN  mutations  in  
developing  cardiac  arrhythmias.                                    
HCN  Channels  and  Pharmacological  Interventions               
As  stated  previously  numerous  molecular,  pharmacological  and  
genetic  (knockout  and  transgenic  mice)  studies  have  verified  
emerging  role  of  these  channels  in  epilepsy,  neuropathic  pain  
and  cardiac  arrythmia.  As  the  very  basic  concept  of  drug  
development  states  that  the   target  (here  HCN  channel)  which  
we  intend  to  exploit  to  alter  the  course  of  disease  or  to  gain  
therapeutic  benefit  must  have  critical  impact  on  the  patho-
physiology  of  disease.  HCN  channels  per se  represent  valid  
targets  for  novel  agents  for  different   clinical  conditions.  These  
evidences  will  be  discussed  in  following  section. 
Ivabradine  was  one  of  the  initial  molecules  whose  mechanism  
of  action  involved  inhibition  of  HCN  ion  channel  which  was  
approved  by  the  European  Medicines  Agency  in  2005  to  be  
used  in  symptomatic treatment of chronic stable angina pectoris.  
Heart  rate reduction  is  a  recognized  therapeutic  target  in  several  
cardiac  conditions,  including  ischemic  heart  disease  and  heart  
failure.  In  ischemic  heart  disease  high  heart  rate  increases  
myocardial  oxygen  demand  and  reduces  diastolic  coronary  blood  
flow  which  aggravates  myocardial ischemia.  Ivabradine  by  
selectively  inhibiting  If   acts  as  heart  rate  lowering  agent  which  
reduces  heart  rate  without  affecting  the  inotropism  and  avoiding  
other  cardiac  side  effects.  This  selective  blocking  of  If  current  
will  definitely  have  important  therapeutic  advantages.  Ivabradine  
has  use and  rate-dependence  action  which   depends  on  open  
close  state  of  channel  itself[57].  Since  it  affects  predominantly  
HCN  channels   it  doesn’t  alter  other  ionic  currents.  In  the  
management  of  chronic  stable  angina  Ivabradine  has  efficacy  
comparable  to  atenolol[58]  and  amlodipine[59].  In  the  
BEAUTIFUL  clinical  trial  of  ivabradine  on  patients  of  coronary  
artery  disease  with  ejection  fraction  <40%  it  was  found   that   
reduction  in  heart  rate  does  not  improve  cardiac  outcomes  in  
all  patients  with  stable  coronary  artery  disease  and  left-
ventricular  systolic  dysfunction,  but  could  be used  to  reduce  the  
incidence  of  coronary  artery  disease  outcomes  in  a  subgroup  of 
patients  who  have  heart  rates  of  70  beats  per  minute  or  
greater[60].  Another  clinical  trial  SHIFT,  involving  patients  with  
symptomatic  heart  failure  and  a  left-ventricular  ejection  fraction  
of 35%  or  lower,  were  in  sinus  rhythm  with  heart  rate  70  beats  
per  min  or  higher  supports  the  importance  of  heart-rate  
reduction  with  ivabradine  for  improvement  of clinical  outcomes  
in  heart  failure  and  confirm  the  important  role  of  heart rate  in  
the patho-physiology  of  this  disorder[61].  Considering  all  these  
clinical  evidences  the  utility  of  ivabradine  seems  to  be  limited  
to  a  restricted  group  of  patients  with  a  sinus  rhythm with a  
heart  rate ≥70 beats  per  minute.  When  given  with  metoprolol,  
ivabradine  has  been  found  to  be  effective  in  treatment  of  
inappropriate sinus tachycardia[62]  characterized   by  excessive  
resting  heart  rate  or  a  disproportional  increase  in  heart  rate 
during exercise,  who  were  refractory  to  monoterapy.  So  it  is  
clear  from  the  above  the  discussion   that  ivabradine  has  got  
adjunctive  role  in  the  management  of  angina  while  of  certain  
advantage  in  management  of  heart  failure.                               
In  the  management  of  neuropathic  pain  HCN  blocker  can  be  of  
therapeutic  advantage  as  their  expression  gets  upregulated  at  
dorsal  root  ganglion  and  ventral-lateral  periaqueductal  gray  
matter  in  case  of  neuronal  injury[63].  Pharmacological blockade  
of  HCN  activity  using  the  specific  inhibitor  ZD7288  reverses  
abnormal  hypersensitivity  to  light  touch  and  decreases  the  firing  
frequency  of  ectopic  discharges without  conduction  blockade48.  
In  the  animal  study  it  is  shown  that  peripheral  block  of Ih  
produces  an  antiallodynic  effect, which  suggests  that  Ih  channels  
represent  a  novel  target  for  nerve  block  treatment  of  
postoperative  and  neuropathic  pain51.  These  data  clearly  
demonstrate  the  beneficial  effects  in  neuropathic  pain  and  
provide  conclusive evidence  for  development  of  HCN  channel  
blockers  for  the  treatment  of  neuropathic  pain[64]. 
“Epileptogenesis  refers  to  the  transformation  of  a  normal  
neuronal  network into  one  that  is  chronically  hyperexcitable.  
There  is  often  a  delay  of  months  to  years between  an  initial  
CNS  injury  such  as  trauma,  stroke,  or  infection  and  the  first  
seizure. The  injury  appears  to  initiate  a  process  that  gradually  
lowers  the  seizure  threshold  in  the affected  region  until  a  
spontaneous  seizure  occurs.  In  many  genetic  and  idiopathic  
forms of  epilepsy,  epileptogenesis  is  presumably  determined  by  
developmentally regulated events”[65].  Genetic  studies  suggest  
that  the  HCN  channelopathy  begins  rapidly  and  persists  after  
status  epilepticus  involving  both  transcriptional  and  non-
transcriptional  mechanisms,  and  may  be  an  early  contributor  to  
epileptogenesis[66].  The  most  compelling experimental  evidence  
linking  reduced  HCN  function  to  epilepsy  has  been  found  using 
the  HCN2  knockout  mouse25.  Since  these  are  the  significant  
genes  for  epilepsy,  they  can  serve  as  drug  target.  Contrary  to  
the  conclusions  drawn  from  animal  studies  HCN2  channel  
inhibitors  can  be  epileptic  because  of  the  larger  current  (35% 
more)  associated  with  mutant  HCN2  which  also  shows  gain  of  
function[67].  Although  these  models  have  thrown  light  on  
mechanism  of  absence  seizure,  to  apply  these  concepts  on  
human  beings  is  still  requires  human  genetic  studies.   Although  
there  is  no  currently  approved  anti-epileptic  drug  which  acts  
selectively  on  HCN  channels,  but  certain  drugs  have  been  shown  
to  involve  HCN  channels  in  their  mechanism.  Lamotrigine  and  
gabapentin  have  been  shown  to  reduce  action  potential firing  in  
dendrites,  by  increasing  Ih,  which  may  be  one  possible  
mechanism  for  their  antiepileptic  action[68,69].  Ketamaine  has  
also  been  shown  to  act  on  HCN1  channel  which  provide  a  
plausible  neuronal  mechanism  for  enhanced cortical  
synchronization  during  anesthetic  induced  hypnosis  and  suggest  
that  HCN1 channels  might  contribute  to  other  unexplained  
actions  of   ketamine[70].  HCN1  channel  is  also  modulated  by  
propofol[71,72]  which  may  be  responsible  for  some of  the  side  
effects  of  propofol,  simultaneously  provides  opportunity  to  
develop  selective  HCN1  channel  inhibitor.  To  conclude,  more  
human  and  animal  studies  are  required  to  uncover  precise 
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physiological  role  of  Ih  in  epilepsy  so  that  we  can  develop  
drugs  which  can  be  used  to  treat  or  atleast  modify  the  course  
of  illness.                                                                  
CONCLUSION                   
Currently  HCN  channels  considered  as  significant  regulators  of  
many  biological  processes  not  only  in  nervous  system  but  in  
the  heart  as  well.  There  is  growing  body  of  evidences   
implicating  changes  in  HCN  channel  function  as  part  of  the  
aetio-pathogenesis  of  neuropathic  pain,  certain  epilepsies  and  
arrythmias.  Especially  HCN2  and  HCN4  both  are  involved  upto  
different  extent  in  these  three  disorders.  Since  the  exact  and  
precise  role  of  HCN  channels  in  neuronal  physiology  is  not  yet  
described  with  certain  gray  areas,   we  first  need  to  clarify  those  
issues.  Animal  models  and  computer  simulation  techniques  have  
certainly  helped  us  in  elaborating  the  physiology  and  genetic  
knockout  studies  have  thrown  light  on  channelopathies,  but  
these  findings  needs  to  be  verified  for  humans  also.  At  present  
we  have  drug  approved  to  be  used  in  cardiac  conditions,  but  no  
drug  is  available  to  be  used   in  other  disorders  that  we  have  
discussed.  Since  many  aspects  of  HCN  channel  still  remains  to  
be  elaborated,  it  will  be  interesting  to  see  how  many  of  
potential  drug  therapies  suggested  for  disorders,  replicate  
themselves  into  actual  clinical  practice.                                                                      
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